Literature DB >> 18444851

Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study.

Lone Graff Stensballe1, Thomas Hjuler, Andreas Andersen, Margit Kaltoft, Henrik Ravn, Peter Aaby, Eric A F Simoes.   

Abstract

BACKGROUND: Previous population-based studies have reported a temporal association between respiratory syncytial virus (RSV) infection and invasive pneumococcal disease (IPD). We examined this association at an individual level in the Danish population.
METHODS: Using registry information about hospitalization for RSV infection and IPD in Denmark, we conducted a prospective, population-based cohort study and examined the associations between hospitalization for RSV infection and IPD.
RESULTS: In our cohort, no persons aged > or =2 years experienced IPD within 30 days after hospitalization for RSV infection. Among children aged <2 years, children who were hospitalized for RSV infection had a significantly increased risk of IPD during the 30 days after hospitalization, compared with those who were not hospitalized for RSV infection (adjusted rate ratio, 7.1; 95% confidence interval, 3.6-14.3). Likewise, hospitalization for a non-RSV respiratory infection increased the risk of IPD during the 30 days after hospitalization (adjusted rate ratio, 4.5; 95% confidence interval, 2.0-10.0). IPD did not increase the risk of hospitalization for RSV infection among children aged <2 years.
CONCLUSIONS: Both recent hospitalization for RSV infection and recent hospitalization for non-RSV respiratory infection increased the risk of IPD among Danish children aged <2 years.

Entities:  

Mesh:

Year:  2008        PMID: 18444851     DOI: 10.1086/529438

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

Review 1.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

2.  Clinical trial report: viral coinfections with invasive pneumococcal disease.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

Review 3.  The role of multiplex PCR in respiratory tract infections in children.

Authors:  Jens Christian Krause; Marcus Panning; Hartmut Hengel; Philipp Henneke
Journal:  Dtsch Arztebl Int       Date:  2014-09-19       Impact factor: 5.594

4.  Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.

Authors:  Wouter A A de Steenhuijsen Piters; Santtu Heinonen; Raiza Hasrat; Eleonora Bunsow; Bennett Smith; Maria-Carmen Suarez-Arrabal; Damien Chaussabel; Daniel M Cohen; Elisabeth A M Sanders; Octavio Ramilo; Debby Bogaert; Asuncion Mejias
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

5.  Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity.

Authors:  Daniel M Weinberger; Lindsay R Grant; Claudia A Steiner; Robert Weatherholtz; Mathuram Santosham; Cécile Viboud; Katherine L O'Brien
Journal:  Clin Infect Dis       Date:  2013-11-03       Impact factor: 9.079

6.  Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia.

Authors:  Irena Kukavica-Ibrulj; Marie-Eve Hamelin; Gregory A Prince; Constance Gagnon; Yves Bergeron; Michel G Bergeron; Guy Boivin
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

7.  Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection.

Authors:  Claire M Smith; Sara Sandrini; Sumit Datta; Primrose Freestone; Sulman Shafeeq; Priya Radhakrishnan; Gwyneth Williams; Sarah M Glenn; Oscar P Kuipers; Robert A Hirst; Andrew J Easton; Peter W Andrew; Christopher O'Callaghan
Journal:  Am J Respir Crit Care Med       Date:  2014-07-15       Impact factor: 21.405

8.  Temporal association in hospitalizations for tuberculosis, invasive pneumococcal disease and influenza virus illness in South African children.

Authors:  Ziyaad Dangor; Alane Izu; David P Moore; Marta C Nunes; Fatima Solomon; Natalie Beylis; Anne von Gottberg; Johanna M McAnerney; Shabir A Madhi
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

9.  Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study.

Authors:  Joanna Murray; Alex Bottle; Mike Sharland; Neena Modi; Paul Aylin; Azeem Majeed; Sonia Saxena
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

10.  Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.

Authors:  Kim S LeMessurier; Hans Häcker; Liying Chi; Elaine Tuomanen; Vanessa Redecke
Journal:  PLoS Pathog       Date:  2013-11-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.